Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $410.65 | 21 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $124.66 | 1 | $0 (2017) |
| Novo Nordisk Inc | $62.24 | 4 | $0 (2023) |
| Lilly USA, LLC | $60.29 | 4 | $0 (2024) |
| Amgen Inc. | $46.90 | 3 | $0 (2024) |
| Corium, LLC | $22.39 | 2 | $0 (2023) |
| AbbVie Inc. | $15.73 | 1 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.19 | 1 | $0 (2021) |
| Nevro Corp. | $13.35 | 1 | $0 (2023) |
| Phathom Pharmaceuticals, Inc. | $13.25 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $13.15 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $87.34 | 6 | Lilly USA, LLC ($31.90) |
| 2023 | $110.27 | 8 | Novo Nordisk Inc ($44.39) |
| 2021 | $59.61 | 4 | Novo Nordisk Inc ($17.85) |
| 2018 | $28.77 | 2 | Amgen Inc. ($17.86) |
| 2017 | $124.66 | 1 | Janssen Pharmaceuticals, Inc ($124.66) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Inflammation | ||||||
| 05/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Inflammation | ||||||
| 05/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/29/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Diabetes | ||||||
| 03/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/06/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Diabetes | ||||||
| 09/26/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: NEUROSCIENCE | ||||||
| 08/31/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Diabetes | ||||||
| 06/13/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 06/13/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $1.88 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 06/01/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Spinal Cord Stimulator | ||||||
| 04/20/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Diabetes | ||||||
| 03/23/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Diabetes | ||||||
| 12/16/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: RESPIRATORY | ||||||
| 05/21/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Diabetes | ||||||
| 05/14/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Diabetes | ||||||
| 06/18/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/10/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Endocrinology | ||||||
| 08/18/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $124.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 281 | 332 | $40,606 | $5,961 |
| 2020 | 11 | 819 | 1,918 | $202,268 | $51,923 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 105 | 109 | $27,206 | $3,825 | 14.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 59 | $9,818 | $1,644 | 16.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 126 | 164 | $3,582 | $492.00 | 13.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 193 | 515 | $123,600 | $33,519 | 27.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 124 | 254 | $40,640 | $9,364 | 23.0% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 52 | 95 | $9,880 | $2,888 | 29.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 203 | 696 | $14,616 | $2,076 | 14.2% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 76 | 77 | $3,080 | $1,505 | 48.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 76 | 77 | $1,386 | $1,221 | 88.1% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 14 | 48 | $2,832 | $555.62 | 19.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 21 | 56 | $3,360 | $509.16 | 15.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 18 | 18 | $1,440 | $141.74 | 9.8% |
| 81003 | Automated urinalysis test | Office | 2020 | 31 | 34 | $714.00 | $75.90 | 10.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2020 | 11 | 48 | $720.00 | $68.24 | 9.5% |
About Dr. Glenn Sherman, D.O
Dr. Glenn Sherman, D.O is a Family Medicine healthcare provider based in Rockport, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982662425.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Glenn Sherman, D.O has received a total of $410.65 in payments from pharmaceutical and medical device companies, with $87.34 received in 2024. These payments were reported across 21 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($410.65).
As a Medicare-enrolled provider, Sherman has provided services to 1,100 Medicare beneficiaries, totaling 2,250 services with total Medicare billing of $57,884. Data is available for 2 years (2020–2021), covering 14 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Rockport, IN
- Active Since 05/03/2006
- Last Updated 11/17/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1982662425
Products in Payments
- INVOKANA (Drug) $124.66
- TRULICITY (Drug) $32.33
- Ozempic (Drug) $31.71
- Rybelsus (Drug) $30.53
- Otezla (Drug) $29.04
- MOUNJARO (Drug) $27.96
- Azstarys (Drug) $22.39
- Prolia (Biological) $17.86
- VRAYLAR (Drug) $15.73
- VYVANSE (Drug) $15.19
- Senza (Device) $13.35
- VOQUEZNA (Drug) $13.25
- FARXIGA (Drug) $13.15
- TRELEGY ELLIPTA (Drug) $12.59
- CHANTIX (Drug) $10.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Rockport
Rimantas Kazakevicius, Md, MD
Family Medicine — Payments: $5,849
Susan Martin, Md, MD
Family Medicine — Payments: $5,045
Mario Perez, D.o, D.O
Family Medicine — Payments: $4,781
Dr. Michael Higginbotham, Md, MD
Family Medicine — Payments: $4,760
Dr. Yvette Alvarez, D.o, D.O
Family Medicine — Payments: $3,320
Dr. Katrina Erickson, M.d, M.D
Family Medicine — Payments: $3,134